CUSTOM DESIGN PERSPECTIVE IN THE PROCESS PARAMETER OPTIMIZATION OF NANO LIPID CARRIERS
Introduction: Nanostructured lipid carrier is an emerging lipid derived delivery system that is rapidly gaining popularity due to the simplicity of manufacturing technique. The primary task in formulating nanoparticles is to optimize the parameters that are involved in the process. The rationale behind this study is to optimize the process parameters for the preparation of nanostructured lipid carriers.
Methods: For the selected techniques hot homogenization with ultra sonication and melt dispersion, the optimization was carried out via statistical analysis software JMP version 13 Pro using custom design approaches. Sonication time, homogenization speed, stirring rate and cooling temperature were selected as factors for hot homogenization. Stirring speed, stirring time and dilution volume were the factors deliberated for melt dispersion. The impact of these factors on the responses, particle size and poly dispersity index were studied. The nanoparticles were prepared according to the ten experimental runs generated by the design. Based on the responses, the design space and optimum framework was selected.
Result: The prediction profiler indicated a maximum desirability at 81% and 80% for hot homogenization and melt dispersion respectively. The actual versus predicted plot of particle size indicated a regression coefficient (R2) of 0.98, and p value of 0.0001 for hot homogenization and for melt dispersion, the corresponding values were 0.95 and 0.0003. For the response polydispersity index these values were 0.92 and 0.0052 for hot homogenization and 0.90 and 0.0024 for melt dispersion.
Conclusion: The endorsing results indicated the authenticity of the model in predicting the significant processing parameters for NLC.
2. Shi F, Wei Z, Zhao Y, Xu X. Nanostructured lipid carriers loaded with baicalin: an efficient carrier for enhanced antidiabetic effects. Pharmacogn Mag.2016;12(47):198–202.
3. Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–184.
4. Negi LM, Jaggi M, Talegaonkara S. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int J Pharm. 2014;461: 403– 410.
5. Li Q, Cai T, Huang Y, Xia X, Cole SPC, Cai Y. A review of the structure, preparation and application of NLCs, PNPs, and PLNs. Nanomater (Basel, Switzerland) [Internet]. 2017 May 27 [cited 2018 May 31];7(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/28554993.
6. Ganesan P, Narayanasamy D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain Chem Pharm. 2017; 6:37–56.
7. Bhagurkar AM, Repka MA, Murthy SN. A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci. 2017;106(4):1085–1091.
8. Gardouh AR, Faheim SH, Nouh AT, Ghorab MM. Influence of formulation factors on the size of nanostructured lipid carriers and nanoemulsions prepared by high shear homogenization. Int J Pharm Pharm Sci. 2018; 10(4):61–75.
9. Pimentel-Moral S, Teixeira MC, Fernandes AR, Borras-Linares I, Arraez-Roman D, Martinez-Ferez A, et al. Polyphenols-enriched hibiscus sabdariffa extract-loaded nanostructured lipid carriers (NLC):Optimization by multi-response surface methodology. J Drug Deliv Sci Technol. 2019;49: 660–667.
10. Maroju RK, Barash S, Brisbane CE. Evaluation of a biologic formulation using customized design of experiment and novel multidimensional robustness diagrams. J Pharm Sci. 2017;1–10.
11. Gupta S, Kesarla R, Chotai N, Misra A, Omri A. Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability. Biomed Res Int. 2017;1–18.
12. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 2009;8:1–15.
13. Uprit S, Kumar Sahu R, Roy A, Pare A. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm. 2013;21(4):379–385.
14. Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Patel RJ, et al. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J.Control.Release. 2020;321: 372-415.
15. Battaglia L, Gallarate M, Panciani PP, Sapino S, Ugazio E, Sapino S, et al. Techniques for the preparation of solid lipid nano and microparticles focus on cerebrospinal fluid: From basic to clinical research view project role of nitric oxide in neurosurgical diseases view project techniques for the preparation of solid lipid nano and microparticles. 2014 [cited 2018 Oct 9]; Available from: http://dx.doi.org/10.5772/58405.
16. Pastor M, Basas J, Vairo C, Gainza G, Moreno-Sastre M, Gomis X, et al. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration. Nanomedicine Nanotechnology Biol Med. 2019;18:101–111.
17. Poonia N, Kaur Narang J, Lather V, Beg S, Sharma T, Singh B, et al. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation. Colloids Surfaces B Biointerfaces . 2019;181:756–766.
18. Du W, Li H, Tian B, Sai S, Gao Y, Lan T, et al. Biointerfaces development of nose to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surfaces B Biointerfaces. 2019;183: 110446.
19. Aliasgharlou L, Ghanbarzadeh S, Azimi H, Zarrintan MH, Hamishehkar H. Nanostructured lipid carrier for topical application of n-acetyl glucosamine. Adv Pharm Bull. 2016;6(4):581–587.
20. Saedi A, Rostamizadeh K, Parsa M, Dalali N, Ahmadi N. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity. Chem Phys Lipids. 2018;216:65–72.
21. Tofani RP, Sumirtapura YC, Darijanto ST. Formulation, characterisation and in vitro skin diffusion of nanostructured lipid carriers for deoxyarbutin compared to a nanoemulsion and conventional cream. Sci Pharm. 2016;84(4):634–645.
22. Injem VK, Sudheer P, Ashwini M. Formulation and evaluation of topical solid lipid nanoparticulate system of clobetasole propionate.Der Pharma Chem.2017;9(22):29-37.
23. Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs. Eur J Pharm Sc. 2012; 47(1):139–151.
24. Shimojo AM, Fernandes AR V, Ferreira NRE. Evaluation of the influence of process parameters on the properties of resveratrol-loaded NLC using 22 full factorial design. Antioxidants (Basel). 2019; 8(8): 272-282.
25. Reul R, Fricker G, Curi A. Formulation optimization of itraconazole loaded PEGylated liposomes for parenteral administration by using design of experiments. Int J Pharm. 2013;448(1):189–197.
This work is licensed under a Creative Commons Attribution 4.0 International License.